{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:13:16Z","timestamp":1784131996305,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrurol.2010.187","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T10:36:45Z","timestamp":1291804605000},"page":"661-667","source":"Crossref","is-referenced-by-count":21,"title":["Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity"],"prefix":"10.1038","volume":"7","author":[{"given":"Christopher","family":"Dowson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shamim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"BFnrurol2010187_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"A Apostolidis","year":"2009","unstructured":"Apostolidis, A. et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European consensus report. Eur. Urol. 55, 100\u2013120 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse, J., Kramer, G. & Stohrer, M. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur. Urol. 47, 653\u2013659 (2005).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"G Karsenty","year":"2006","unstructured":"Karsenty, G., Reitz, A., Lindemann, G., Boy, S. & Schurch, B. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 68, 1193\u20131197 (2006).","journal-title":"Urology"},{"key":"BFnrurol2010187_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","volume":"100","author":"M Akbar","year":"2007","unstructured":"Akbar, M. et al. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int. 100, 639\u2013645 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol2010187_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ana.21209","volume":"62","author":"V Kalsi","year":"2007","unstructured":"Kalsi, V. et al. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann. Neurol. 62, 452\u2013457 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrurol2010187_CR6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"A Reitz","year":"2007","unstructured":"Reitz, A. et al. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur. Urol. 52, 1729\u20131735 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","volume":"53","author":"PG Del","year":"2008","unstructured":"Del, P. G. et al. Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur. Urol. 53, 1013\u20131019 (2008).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","volume":"55","author":"A Giannantoni","year":"2009","unstructured":"Giannantoni, A., Mearini, E., Del, Z. M. & Porena, M. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur. Urol. 55, 705\u2013711 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11255-009-9528-y","volume":"41","author":"IF Ghalayini","year":"2009","unstructured":"Ghalayini, I. F., Al-Ghazo, M. A. & Elnasser, Z. A. Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport\u00ae) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity. Int. Urol. Nephrol. 41, 805\u2013813 (2009).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol2010187_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","volume":"104","author":"J Pannek","year":"2009","unstructured":"Pannek, J., Gocking, K. & Bersch, U. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction. BJU Int. 104, 1246\u20131250 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2010187_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.urology.2009.05.097","volume":"75","author":"A Sahai","year":"2010","unstructured":"Sahai, A., Dowson, C., Khan, M. S. & Dasgupta, P. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. Urology 75, 552\u2013558 (2010).","journal-title":"Urology"},{"key":"BFnrurol2010187_CR12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.juro.2008.11.110","volume":"181","author":"S Khan","year":"2009","unstructured":"Khan, S. et al. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type A injection. J. Urol. 181, 1773\u20131778 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol2010187_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00192-007-0548-9","volume":"19","author":"S Kuschel","year":"2008","unstructured":"Kuschel, S., Werner, M., Schmid, D. M., Faust, E. & Schuessler, B. Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 905\u2013909 (2008).","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"BFnrurol2010187_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00345-008-0362-0","volume":"27","author":"U Mehnert","year":"2009","unstructured":"Mehnert, U. et al. A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging. World J. Urol. 27, 397\u2013403 (2009).","journal-title":"World J. Urol."},{"key":"BFnrurol2010187_CR15","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","volume":"28","author":"F Antonucci","year":"2008","unstructured":"Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O. & Caleo, M. Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 28, 3689\u20133696 (2008).","journal-title":"J. Neurosci."},{"key":"BFnrurol2010187_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.eururo.2008.02.037","volume":"53","author":"A Apostolidis","year":"2008","unstructured":"Apostolidis, A. et al. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur. Urol. 53, 1245\u20131253 (2008).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comperat","year":"2006","unstructured":"Comperat, E. et al. Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur. Urol. 50, 1058\u20131064 (2006).","journal-title":"Eur. Urol."},{"key":"BFnrurol2010187_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1442-2042.2008.02016.x","volume":"15","author":"H Schulte-Baukloh","year":"2008","unstructured":"Schulte-Baukloh, H. et al. Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure. Int. J. Urol. 15, 407\u2013415 (2008).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2010187_CR19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014107689208500906","volume":"85","author":"TJ Anderson","year":"1992","unstructured":"Anderson, T. J. et al. Botulinum toxin treatment of spasmodic torticollis. J. R. Soc. Med. 85, 524\u2013529 (1992).","journal-title":"J. R. Soc. Med."},{"key":"BFnrurol2010187_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mds.870090216","volume":"9","author":"P Greene","year":"1994","unstructured":"Greene, P., Fahn, S. & Diamond, B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov. Disord. 9, 213\u2013217 (1994).","journal-title":"Mov. Disord."},{"key":"BFnrurol2010187_CR21","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","volume":"45","author":"J Jankovic","year":"1995","unstructured":"Jankovic, J. & Schwartz, K. Response and immunoresistance to botulinum toxin injections. Neurology 45, 1743\u20131746 (1995).","journal-title":"Neurology"},{"key":"BFnrurol2010187_CR22","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","volume":"43","author":"M Zuber","year":"1993","unstructured":"Zuber, M., Sebald, M., Bathien, N., de Recondo, J. & Rondot, P. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43, 1715\u20131718 (1993).","journal-title":"Neurology"},{"key":"BFnrurol2010187_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","volume":"60","author":"J Jankovic","year":"2003","unstructured":"Jankovic, J., Vuong, K. D. & Ahsan, J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60, 1186\u20131188 (2003).","journal-title":"Neurology"},{"key":"BFnrurol2010187_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/jnnp.2006.093419","volume":"78","author":"D Dressler","year":"2007","unstructured":"Dressler, D. & Adib, S. F. New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia. J. Neurol. Neurosurg. Psychiatry 78, 108\u2013109 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 8","key":"BFnrurol2010187_CR25","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1002\/mds.20022","volume":"19","author":"D Dressler","year":"2004","unstructured":"Dressler, D. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov. Disord. 19 (Suppl. 8), S92\u2013S100 (2004).","journal-title":"Mov. Disord."},{"issue":"Suppl. 1","key":"BFnrurol2010187_CR26","first-page":"74","volume":"23","author":"P Sangster","year":"2009","unstructured":"Sangster, P. et al. Is the Extensor digitorum brevis test useful in predicting resistance to treatment with botulinum toxin-A for patients with overactive bladder [abstract MP23-04]? J. Endourol. 23 (Suppl. 1), 74 (2009).","journal-title":"J. Endourol."},{"key":"BFnrurol2010187_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000081463","volume":"52","author":"D Dressler","year":"2004","unstructured":"Dressler, D. & Bigalke, H. Antibody-induced failure of botulinum toxin type B therapy in de novo patients. Eur. Neurol. 52, 132\u2013135 (2004).","journal-title":"Eur. Neurol."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T12:16:17Z","timestamp":1685880977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2010.187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrurol2010187"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2010.187","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}